Summary Definition Tirzepatide: A dual GIP and GLP-1 receptor agonist that mimics natural gut hormones to improve glucose control, weight loss, cardiovascular health, and organ protection by acting on the brain, pancreas, liver, heart, kidneys, adipose tissue, and muscles Impressive work highlighting Tirzepatides multi-system impact its dual GIP/GLP-1 agonism delivers coordinated benefits across the brain, heart, liver, and adipose tissue, driving improved metabolism, insulin sensitivity, and cardiometabolic health.
Of most importance are the stimulation of beta cell function, reduction of glucagon secretion and delay in gastric emptying, which together lower fasting and postprandial glucose and HbA 1c levels
Tirzepatide works through a gradual titration schedule, meaning your starting dose is intentionally lower than your maintenance dose to minimize side effects and allow your body to adapt
Although the behavior of SFTs cannot be always predicted by histopathology, the presence of frequent mitoses, hypercellularity, pleomorphism, and necrosis is generally associated with malignant behavior